Inventaire - deine Freunde und Communitys sind die beste Bibliothek für dich

Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study).

Autor

Alan V. Boddy

Jean-Pierre Pignon

Le Deley

veröffentlicht in: Pediatric Blood & Cancer

Erscheinungsdatum: 2017-01-23

Hauptthema: Ifosfamid

Zitiert Artikel 26

Datum

Titel

Autor

2015-08-10

Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial.

Le Deley, Gwénaël Le Teuff, Hans Gelderblom
2015-04-01

Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement

Richard D. Riley, Maroeska M. Rovers, Lesley A Stewart, Mark Crawford Simmonds, Mike Clarke, Jayne Tierney
2014-06-30

Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial

Le Deley, Gwénaël Le Teuff, Perrine Marec-Bérard, Andreas Ranft, Ian Judson
2014-02-01

Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women
2013-05-13

Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis

Matthew R Sydes, Piero Picci, David M Thomas, Hans Gelderblom, Marnie Collins
2013-12-06

Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age

Roberto Luksch, Franca Fagioli, Marilena Cesari, Emanuela Palmerini, Angela Tamburini, Anna Paioli, Massimo Eraldo Abate
2012-09-25

Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I).

Richard Adams, David Sebag-Montefiore
2011-07-12

Sex disparities in cancer mortality and survival

Susan Shaw Devesa, Katherine A. McGlynn
2011-03-16

A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners

Andrew Copas, Jayne Tierney
2011-01-28

Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial

Audrey Mauguen, Le Deley
2009-03-17

Sex disparities in cancer incidence by period and age.

Susan Shaw Devesa, Katherine A. McGlynn
2009-07-01

Gender-specific activity of chemotherapy correlates with outcomes in chemosensitive cancers of young adulthood.

Guy Toner, Jayesh Desai, David M Thomas
2009-04-01

Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcoma

Emanuela Palmerini, Eric L Staals, Alessandra Longhi, Marilena Cesari
2009-05-29

Sex differences in the expression of hepatic drug metabolizing enzymes

David J. Waxman
2008-09-01

Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.

Christopher Poremba
2006-07-01

Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial
2005-01-01

Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics
2003-09-06

Measuring inconsistency in meta-analyses

Doug Altman, Julian Higgins, Jon Deeks
2003-10-01

Sex is a major determinant of CYP3A4 expression in human liver.

Peter Neuhaus, Ulrich M. Zanger
2003-10-09

Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression

Stephen C Strom, Peter K. Rogan
2001-08-01

Gender and survival in malignant tumours

Paul Lorigan
2001-06-01

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease
2001-07-01

Gender difference in ifosfamide metabolism by human liver microsomes
2000-04-01

Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide

David J. Waxman
1995-10-01

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group
1994-03-01

Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide

Artikel - wd:Q39006166

Willkomen bei Inventaire

die Bibliothek deiner Freunde und Communitys

entdecke mehr